{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "36-year-old man diagnosed with metastatic ALK-rearranged NSCLC.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C4970",
              "label": "Secondary malignant neoplasm of lung",
              "status": "active",
              "onset_date": null
            }
          ]
        }
      }
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "Patient received crizotinib and platinum-doublet chemotherapy.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0884174",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "platinum-doublet chemotherapy",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ]
        }
      }
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "Patient developed toxic hepatitis after 3 months of crizotinib.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C0262714",
              "label": "Toxic hepatitis",
              "status": "active",
              "onset_date": null
            }
          ],
          "medications": [
            {
              "drug": "C1959349",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ]
        }
      }
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "Patient received lorlatinib after crizotinib and platinum-doublet chemotherapy.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C1705635",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "C5203808",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ],
          "procedures": [
            {
              "name": "C0007327",
              "approach": null,
              "date": null,
              "location": null,
              "performed_by": null,
              "outcome": null
            }
          ]
        }
      }
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "Patient developed acute pancreatitis due to hypertriglyceridemia after 4 months of lorlatinib.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C0030701",
              "label": "Pancreatitis, Acute",
              "status": "active",
              "onset_date": null
            }
          ],
          "medications": [
            {
              "drug": "C4049254",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ]
        }
      }
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "Patient admitted to hospital with a cough and back pain for 1 month. October 2016: Fluorodeoxyglucose (FDG)-positron emission tomography (PET) computed tomography (CT) scan revealed a mass of approximately 4 cm in the right upper lobe of the lung, accompanied by multiple mediastinal, hilar, bilateral supraclavicular, left retroclavicular lymph node metastases and bone metastasis.",
        "clinical_data": {
          "HPI": [
            {
              "duration": "1 month",
              "associated_symptoms": [
                "C0010200"
              ]
            }
          ],
          "imaging": [
            {
              "type": "C0024142",
              "body_part": "C0205862",
              "modality": "CT",
              "finding": "mass of approximately 4 cm in the right upper lobe of the lung, accompanied by multiple mediastinal, hilar, bilateral supraclavicular, left retroclavicular lymph node metastases and bone metastasis",
              "date": "2016-10"
            },
            {
              "type": "C0024142",
              "body_part": "C0205862",
              "modality": "PET",
              "finding": "mass of approximately 4 cm in the right upper lobe of the lung, accompanied by multiple mediastinal, hilar, bilateral supraclavicular, left retroclavicular lymph node metastases and bone metastasis",
              "date": "2016-10"
            }
          ]
        }
      }
    },
    {
      "id": "N7",
      "label": "Step 7",
      "customData": {
        "node_id": "G",
        "node_step_index": 6,
        "content": "Tru-Cut biopsy from the mass in the upper lobe of the right lung revealed SRC carcinoma with an inversion of the EML4-ALK gene detected by immunohistochemistry and fluorescence in situ hybridization.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Mass",
              "body_part": "Upper lobe of the right lung",
              "modality": "Tru-Cut biopsy",
              "finding": "SRC carcinoma",
              "date": null
            }
          ],
          "diagnoses": [
            {
              "code": null,
              "label": "SRC carcinoma",
              "status": "active",
              "onset_date": null
            }
          ],
          "labs": [
            {
              "test": "EML4-ALK gene",
              "value": "inversion detected",
              "unit": null,
              "flag": "abnormal",
              "reference_range": null,
              "timestamp": null
            }
          ]
        }
      }
    },
    {
      "id": "N8",
      "label": "Step 8",
      "customData": {
        "node_id": "H",
        "node_step_index": 7,
        "content": "November 2016: Crizotinib (250 mg twice daily) was initiated as the first-line treatment.",
        "clinical_data": {
          "medications": [
            {
              "drug": "Crizotinib",
              "dosage": "250 mg",
              "frequency": "twice daily",
              "modality": "oral",
              "start_date": "2016-11",
              "end_date": null,
              "indication": "first-line treatment"
            }
          ]
        }
      }
    },
    {
      "id": "N9",
      "label": "Step 9",
      "customData": {
        "node_id": "I",
        "node_step_index": 8,
        "content": "Follow-up PET after 3 months showed the size and metabolic activity of the primary lesion and lymph nodes remarkably decreased.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Positron emission tomography",
              "body_part": "primary lesion and lymph nodes",
              "modality": "PET",
              "finding": "size and metabolic activity remarkably decreased",
              "date": null
            }
          ]
        }
      }
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "Initiation of treatment for metastatic ALK-rearranged NSCLC."
      }
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "Adverse reaction to crizotinib.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C1959349"
          ],
          "change_type": "other",
          "target_domain": "diagnosis"
        }
      }
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "Change in treatment regimen following toxic hepatitis from crizotinib.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C1705635",
            "C5203808"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "Adverse reaction to lorlatinib.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C4049254"
          ],
          "change_type": "other",
          "target_domain": "diagnosis"
        }
      }
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "Patient admitted to hospital with a cough and back pain. Imaging reveals mass and metastases.",
        "transition_event": {
          "trigger_type": "symptom_onset",
          "trigger_entities": [
            "C0010200"
          ],
          "change_type": "progression",
          "target_domain": "symptom"
        }
      }
    },
    {
      "from": "N6",
      "to": "N7",
      "data": {
        "edge_id": "F_to_G",
        "branch_flag": true,
        "content": "Biopsy confirms SRC carcinoma with EML4-ALK gene inversion.",
        "transition_event": {
          "trigger_type": "lab_change",
          "trigger_entities": [
            "EML4-ALK gene"
          ],
          "change_type": "other",
          "target_domain": "diagnosis"
        }
      }
    },
    {
      "from": "N7",
      "to": "N8",
      "data": {
        "edge_id": "G_to_H",
        "branch_flag": true,
        "content": "Initiation of crizotinib as first-line treatment.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "Crizotinib"
          ],
          "change_type": "addition",
          "target_domain": "medication",
          "timestamp": "2016-11"
        }
      }
    },
    {
      "from": "N8",
      "to": "N9",
      "data": {
        "edge_id": "H_to_I",
        "branch_flag": true,
        "content": "Follow-up PET scan shows decreased size and metabolic activity of the primary lesion and lymph nodes.",
        "transition_event": {
          "trigger_type": "imaging",
          "trigger_entities": [
            "Positron emission tomography"
          ],
          "change_type": "resolution",
          "target_domain": "imaging"
        }
      }
    }
  ]
}